Related Experiment Video
Updated: Apr 18, 2026

08:53
Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma
Published on: June 10, 2017
10.6K
How I treat advanced classical Hodgkin lymphoma
Peter Johnson1, Hayley McKenzie1
1Cancer Research UK Center, University of Southampton, Southampton, United Kingdom.
Blood
|January 8, 2015
Summary
Curative treatments for Hodgkin lymphoma offer high cure rates but have limitations. Modern approaches aim to improve outcomes and reduce long-term side effects using advanced imaging and new therapies.
Area of Science:
- Oncology
- Hematology
Background:
- Hodgkin lymphoma treatment has seen significant advances, achieving over 80% cure rates.
- Despite high cure rates, limitations include treatment failures in some patients and significant long-term side effects.
Observation:
- Conventional treatments combining chemotherapy and radiotherapy have shown limited progress in recent decades.
- New therapeutic strategies are emerging to address the unmet needs in Hodgkin lymphoma management.
Findings:
- Functional imaging, specifically (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET), allows early assessment of treatment response.
- Novel agents, including antibody-drug conjugates, demonstrate high activity and promise for improved outcomes.
Implications:
- Integrating FDG-PET can optimize treatment strategies by identifying early treatment failures.
- Novel agents like antibody-drug conjugates represent a promising frontier for enhancing Hodgkin lymphoma cure rates while mitigating toxicity.
Related Concept Videos
Treatment Resistent Cancers
1.5K
1.5K
Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Tumor Immunotherapy
2.6K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.6K
Targeted Cancer Therapies
9.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.2K
Combination Therapies and Personalized Medicine
6.4K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K
Bone Marrow Sampling and Transplants
2.8K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.8K

